Finally allowed to tell everyone.. .. I am officially a virologist again! #HBV #HepatitisB Check out @yecuris for more info, see you in person tomorrow in Seattle ISAR's #liveICAR2022 yecuris.com/infectious-dis…

We are excited to announce that we’re launching in vivo HBV CRO services! Contact us today to learn more about our Oregon-based liver-humanized mice and HBV offerings #liveICAR2022 #HBV

Our liver-humanized mouse model can replace the use of NHPs for in vivo research of hepatotropic diseases like #hepatitisb #HBV. Check out yecuris.com/infectious-dis… #liveICAR2022

Molly Woodson presenting PhD research on RNase H inhibitor development Saint Louis University. This is an update on their paper using our liver-humanized model: pubmed.ncbi.nlm.nih.gov/29129708/ Improving compounds so we can test in vivo @yecuris, and one day start treating patients! #liveICAR2022

Check out our newest paper!

Lots of #ASGCT22 abstracts on @GeneTherapy #CellTherapy and beyond using our #liverhumanizedmouse @yecuris @yecuris! First: We show that GalNAc siRNA can knock down human C5 produced by human hepatocytes in vivo annualmeeting.asgct.org/abstracts/abst…

Lots of #ASGCT22 abstracts on #GeneTherapy #CellTherapy and beyond using our #liverhumanizedmouse from @yecuris! First poster: We show that GalNAc siRNA can knock down human C5 produced by human hepatocytes in vivo annualmeeting.asgct.org/abstracts/abst…

Jack Scannell Humanized liver mice (tissue level not genetic) like from Yecuris allowed us to test drugs against hepatotropic pathogens that only infect humans (eg HepC and malaria), in vivo in animals for the first time.

We might have a few publications on this... yecuris.com/publications

Dr Timos Papagatsias honored to be collaborating with the people @ambysmedicines using the FRG technology platform from @yecuris.

Our liver-humanized mouse model can also be used here to de target the liver so other organs can be hit.

We were honored to be invited to the residence of the Belgian ambassador in Washington DC to discuss our scientific achievements during #ASGCT22.

Here at poster 94 showing how GalNAc-siRNA can knock down human C5 in vivo in our @yecuris liver-humanized mouse model. Come and meet me! #ASGCT22

Thanks Jonathan Gootenberg and Omar Abudayyeh for the mention during you PASTE talk at #ASGCT22. Honored that our liver-humanized FRG mouse model Yecuris was put to good use! The publication should be out soon, check out the previous preprint version: biorxiv.org/content/10.110…

Efrain Guzman delivering his poster presentation on lentiviral-transduced hepatocytes, Wednesday 12p - 2p. See where the #yecuris liver-humanized mouse platform helps in the advancement of gene therapy. #ASGCT2023

Yecuris will be in Kobe, Japan next week at the International HBV Meeting coordinated by the Hep B Foundation! Let us know if you are at the meeting and would like to know more about the collaborative difference of using Yecuris liver-humanized mice. hubs.li/Q022b52p0

We are excited to be in Boston at The Liver Meeting this year with AASLD Foundation. Looking forward to all of the great new developments in hepatology. Grab your badge and come see us in Exhibit Hall B, booth 1022 starting with the welcome reception Saturday night! #TLM2023

This morning at #TLM2023, an important session you can’t miss. Humanized Models: Tools to Advance Liver Research in the Sheraton Hotel Grand Ballroom. Attend part 2 at 11:30am and then come see us in Hall B, booth 1022 to plan out your next research steps with human relevance.

Yecuris Corporation is proud to join the Janvier Group! Read more about this exciting news here. hubs.li/Q02j43Vp0